| Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19 | European Respiratory Journal | 2020 | 142 |
| Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Central Nervous System | Trends in Neurosciences | 2020 | 134 |
| Distinct phenotypes require distinct respiratory management strategies in severe COVID-19 | Respiratory Physiology and Neurobiology | 2020 | 94 |
| The emerging role of neutrophil extracellular traps in severe acute respiratory syndrome coronavirus 2 (COVID-19) | Scientific Reports | 2020 | 85 |
| The potential of mesenchymal stem cell therapy for chronic lung disease | Expert Review of Respiratory Medicine | 2020 | 58 |
| Static and Dynamic Contributors to Ventilator-induced Lung Injury in Clinical Practice. Pressure, Energy, and Power | American Journal of Respiratory and Critical Care Medicine | 2020 | 45 |
| Pros and cons of corticosteroid therapy for COVID-19 patients | Respiratory Physiology and Neurobiology | 2020 | 40 |
| Current understanding of the therapeutic benefits of mesenchymal stem cells in acute respiratory distress syndrome | Cell Biology and Toxicology | 2020 | 39 |
| Brain-heart interaction after acute ischemic stroke | Critical Care | 2020 | 34 |
| Gut Microbiota in Acute Ischemic Stroke: From Pathophysiology to Therapeutic Implications | Frontiers in Neurology | 2020 | 31 |
| Palmitate Is Increased in the Cerebrospinal Fluid of Humans with Obesity and Induces Memory Impairment in Mice via Pro-inflammatory TNF-α | Cell Reports | 2020 | 31 |
| Neurological Manifestations of Severe SARS-CoV-2 Infection: Potential Mechanisms and Implications of Individualized Mechanical Ventilation Settings | Frontiers in Neurology | 2020 | 31 |
| Emerging pharmacological therapies for ARDS: COVID-19 and beyond | Intensive Care Medicine | 2020 | 27 |
| Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential | Cytotherapy | 2020 | 23 |
| Inflammatory signaling in dengue-infected platelets requires translation and secretion of nonstructural protein 1 | Blood Advances | 2020 | 21 |
| Chest physiotherapy: An important adjuvant in critically ill mechanically ventilated patients with COVID-19 | Respiratory Physiology and Neurobiology | 2020 | 21 |
| Emerging trends in COVID-19 treatment: learning from inflammatory conditions associated with cellular therapies | Cytotherapy | 2020 | 21 |
| Mesenchymal Stromal Cells Protect the Blood-Brain Barrier, Reduce Astrogliosis, and Prevent Cognitive and Behavioral Alterations in Surviving Septic Mice | Critical Care Medicine | 2020 | 20 |
| Neurological Complications and Noninvasive Multimodal Neuromonitoring in Critically Ill Mechanically Ventilated COVID-19 Patients | Frontiers in Neurology | 2020 | 20 |
| Multiple doses of adipose tissue-derived mesenchymal stromal cells induce immunosuppression in experimental asthma | Stem Cells Translational Medicine | 2020 | 19 |
| Effects of higher PEEP and recruitment manoeuvres on mortality in patients with ARDS: a systematic review, meta-analysis, meta-regression and trial sequential analysis of randomized controlled trials | Intensive Care Medicine Experimental | 2020 | 18 |
| Adipose Mesenchymal Cells-Derived EVs Alleviate DOCA-Salt-Induced Hypertension by Promoting Cardio-Renal Protection | Molecular Therapy - Methods and Clinical Development | 2020 | 18 |
| Personalized pharmacological therapy for ARDS: a light at the end of the tunnel | Expert Opinion on Investigational Drugs | 2020 | 18 |
| Purinergic signaling in infectious diseases of the central nervous system | Brain, Behavior, and Immunity | 2020 | 16 |
| Nanoparticle-based thymulin gene therapy therapeutically reverses key pathology of experimental allergic asthma | Science Advances | 2020 | 15 |
